
GHK-Cu
Copper peptide isolated from human plasma albumin by Loren Pickart in 1973. Plasma levels decline by 60% between age 20 and 60.
Select Dosage
Quantity
Bundle & Save
Research Use Only. This product is intended for laboratory research purposes only. Not for human or veterinary use. Not for sale to minors.
GHK-Cu — Key Data
A snapshot of published research on GHK-Cu. Each figure links to the literature summarized below.
Multi-Pathway Regeneration
GHK-Cu is a naturally occurring copper-binding tripeptide first isolated from human plasma albumin by Loren Pickart in 1973. It modulates over 4,000 human genes, with 59% upregulated and 41% downregulated. The pattern researchers describe is consistent with a younger gene expression profile, affecting DNA repair, antioxidant defense, neuronal function, and inflammation. For research use only.
Discovered 1973200+ publicationsFirst isolated from human plasma albumin by Loren Pickart
- 01
Gene Expression Remodeling
PrimaryGEEpigenetic Modulation
- 31.2% of human genes affected at greater than 50% change
- 47 DNA repair genes upregulated, only 5 downregulated
- 14 antioxidant genes upregulated, only 2 downregulated
- 02
Collagen / ECM Remodeling
StrongestCOLStructural Regeneration
- 70% collagen synthesis increase with LED irradiation
- Stimulates decorin synthesis for collagen fibril organization
- 9x collagen increase in wound models
- 03
Neuronal / Anti-Anxiety Pathway
SecondaryCu2+Neuroprotective Signaling
- 408 neuronal genes upregulated, 230 downregulated
- OPRM1 (opioid mu receptor) upregulated 1,294%
- GABRA5 receptor subunit upregulated 392%
What the Studies Show
Peer-reviewed outcomes from published GHK-Cu research.
12-Week Facial Study - 71 Women
0
Nano-lipid carrier formulation vs control showed significant wrinkle volume reduction.
- GHK-Cu vs Control
- -55.8%
- GHK-Cu vs Matrixyl
- -31.6%
- Placebo
- 0%
Trial details. 12-week double-blind study, 71 female participants, nano-lipid carrier delivery system
Abdulghani et al., 1998Additional Clinical Outcomes
- 0Pickart et al., 2014
Broad Institute Connectivity Map Analysis
Analysis of 13,424 genes via 22,277 probe sets using Broad Institute Connectivity Map data. 59% upregulated, 41% downregulated.
- 0EurekAlert / Clinical Trial
21-Subject Clinical Trial - 3 Months
21-subject clinical trial with 3 months daily application measured by dermal ultrasound. Top quartile responders showed 51% increase.
- 0Pickart et al., 2018
Emphysema Gene Expression Model
Gene expression pattern reset toward health in emphysema model. Also decreased MMP-2 and MMP-9 in wounds.
Collagen Synthesis Comparison
12-week thigh skin trial comparing collagen increase (Abdulghani et al., 1998)
Research Applications
Reported areas of investigation across the GHK-Cu literature.
- 01SKIN REGENERATION
Wrinkle and Photoaging Reversal
Clinically demonstrated collagen density increase and wrinkle volume reduction across multiple trials.
- Wrinkle volume reduction
- -55.8%
- Collagen density increase
- +28%
- Top quartile response
- +51%
Study finding. 71-woman study showed GHK-Cu nano-lipid carrier outperformed both Matrixyl and placebo for wrinkle reduction.
Abdulghani et al., 1998 - 02WOUND HEALING
Accelerated Tissue Repair
9x collagen increase in wound models with decorin-mediated fibril organization for stronger tissue.
- Collagen increase
- 9x
- Decorin synthesis
- Stimulated
Study finding. Wound models showed 9-fold increase in collagen production alongside organized fibril architecture.
- 03GENE MODULATION
Genome-Wide Expression Reset
Modulates 4,000+ genes with a pattern consistent with younger gene expression, favoring DNA repair and antioxidant defense.
- DNA repair genes upregulated
- 47
- Antioxidant genes upregulated
- 14
- COPD genes reversed
- 127
Study finding. Broad Institute data shows GHK-Cu shifts 31.2% of the genome toward a younger expression profile.
Pickart et al., 2014 - 04NEUROPROTECTION
Neuronal Gene Activation
Upregulates 408 neuronal genes while activating opioid and GABA receptor systems.
- OPRM1 upregulation
- +1,294%
- GABRA5 upregulation
- +392%
Study finding. Neuronal gene modulation suggests potential anxiolytic and neuroprotective effects independent of copper delivery.
Reported Observations
- GHK-Cu is a naturally occurring peptide in human blood plasma
- Plasma levels decline with age (200 ng/mL at 20 to 80 ng/mL at 60)
- Clinical studies (71 women photoaging, 41 women eye cream, 67 women keratinocyte) report no significant adverse events
This summary reflects observations from published peer-reviewed research. It is not a comprehensive safety assessment. Researchers should review primary literature before designing protocols. For Research Use Only.
Compound Profile
What Is GHK-Cu?
Stability Information
- Protect from light and moisture
- Store in copper-compatible containers
- Avoid repeated freeze-thaw cycles
Lyophilized
Up to 2 years
Reconstituted
Up to 30 days
Working solution
Use within 24 hours
References
Pickart et al., 2015
These references are provided for informational purposes. Kern is not affiliated with the authors or institutions listed above.
Related Products
Important Notice — Please Read
The statements made within this website have not been evaluated by the US Food and Drug Administration. The products we offer are not intended to diagnose, treat, cure, or prevent any disease. The peptides sold on this website are intended for research use only. The buyer is responsible for adhering to all local laws and regulations. Kern is not a pharmacy and does not provide medical advice or prescriptions. They are not for human consumption, are not FDA approved, and are not supplements or pharmaceutical drugs. The information provided on this website is for informational purposes and not a substitute for professional medical advice, diagnosis, or treatment. If you have questions or concerns about your health, please talk to your doctor. This site is an advertisement for education, research peptides, and not any specific medication. By purchasing from Kern, you confirm that you are a qualified researcher purchasing these compounds for legitimate in vitro or laboratory research purposes only. You must be 21 years of age or older to purchase.





